top of page
Female Scientist Using Microscope


CONNECT is a public-private consortium driving the implementation of precision cancer medicine by jointly addressing key obstacles and piloting novel solutions to transform the current practice.

The consortium has been initiated by 22 founding partners in December 2020, attracted 6 additional partners since then and is coordinated by Oslo Cancer Cluster. CONNECT gathers all Norwegian university hospitals, pharmaceutical and technology companies, the Norwegian Cancer Society as patient organisation, the Norwegian Institute of Public Health, the Norwegian Directorate of Health as well as the Norwegian Medicines Agency. The consortium is open to include new partners from the industry and public sector.


“A culture for public-private collaboration is not created through strategic plans, political ambitions or celebratory speeches, but through actions and behaviours that set a new standard.”

—  Lars Petter Strand, Head of Medical at Novartis Oncology Norway


Upcoming Events

  • Advancing Precision Cancer Medicine via European Collaboration
    18 Apr, 12:00 – 13:00
    Webinar via Zoom
    CONNECT seminar that will give an update on precision cancer medicine EU projects and MATRIX
  • Nordic Precision Medicine Forum 2023
    27 Apr, 08:00 – 28 Apr, 16:30
    Södermalm, 118 25 Stockholm, Sweden
    One venue, two days, three inextricably linked meetings


Via Oslo Cancer Cluster

Ullernchausséen 64-66, 0379 Oslo

Jutta Heix, Project Manager, CONNECT

Thanks for submitting!

bottom of page